This is the adjustment period where your body adapts to the new signaling
Whilst generally well-tolerated, like all medications, GLP-1 agonists carry potential side effects that patients and healthcare professionals should understand, including concerns about pancreatic safety that warrant careful consideration
But when it starts to thin or break down, wrinkles, sagging, and fine lines begin to appear
The journal Science reports on the setback
Patent protections will likely keep generics off the market until the early 2030s
*Correspondence: Tongzhi Wu [email protected] This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers